Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CG Oncology
Biotech
Funding at 'new normal' until interest rates change: PitchBook
Funding levels quarter over quarter have stayed relatively stable, defining a new normal for biopharma until federal interest rates change.
Gabrielle Masson
Jun 6, 2024 12:01am
CG sets new bar in bladder cancer, months after huge IPO
May 3, 2024 11:23am
'Next wave of IPOs' will arrive in summer, predicts VC partner
May 3, 2024 10:49am
AbbVie names CEO successor—Chutes & Ladders
Feb 23, 2024 9:30am
VC closes $260M fund for early-stage biotechs
Feb 22, 2024 10:45am
Alto aims for $101M IPO to pave neuro development climb
Jan 30, 2024 11:37am
